Background - Practices (Details)

Pharmaceuticals & Life Sciences

CONTACTS +

Speeches & Presentations

  • "The Patent Prosecution Lifecycle," Pennsylvania Biotechnology Center, Doylestown, PA (February 26, 2020). Speakers: Terry Rea and Mena Gaballah, PharmD.
  • "Fireside Chat: An Interview With: Stacy Amin," ACI's Women Leaders in Life Sciences Law, Boston, MA (July 25, 2019). Interviewer: Terry Rea.
  • "Introduction to FDA Review and Approval of Drugs & Biologics," Introduction to Drug, Biologics, and Biosimilars Law and Regulation, Boston, MA (July 23, 2019). Presenter: Terry Rea.
  • "Concurrent Session 1A Recent Developments: Biosimilar Challengers in PTAB Proceedings," 2019 PTAB Bar Association Annual Conference, Washington, D.C. (March 14, 2019). Presenter: Terry Rea.
  • "Intellectual Property for the Micro-Entrepreneur," Crowell & Moring, New York, NY (December 13, 2017). Presenters: James K. Stronski, Anne Elise Herold Li, and Preetha Chakrabarti.
  • "Regulation of Nanomaterials," The Annual Toxic Substances Control Act Seminar, Washington, D.C. (April 26, 2017). Presenter: Michael Boucher.
  • "Section 8(a) Chemical Data Reporting Rule," The Annual Toxic Substances Control Act Seminar, Washington, D.C. (April 26, 2017). Presenter: Michael Boucher.
  • "Section 8(a) Preliminary Assessment Information Rule and Section 8(d) Health and Safety Data Reporting Rule," The Annual Toxic Substances Control Act Seminar, Washington, D.C. (April 26, 2017). Presenter: Michael Boucher.
  • "Implementation of the Lautenberg Chemical Safety Act," The Annual Toxic Substances Control Act Seminar, Washington, D.C. (April 26, 2017). Presenter: Michael Boucher.
  • "Regulation of New Chemicals and New Uses," The Annual Toxic Substances Control Act Seminar, Washington, D.C. (April 25, 2017). Presenter: Michael Boucher.
  • "Introduction to TSCA," The Annual Toxic Substances Control Act Seminar, Washington, D.C. (April 25, 2017). Presenter: Michael Boucher.
  • "Testing under TSCA," The Annual Toxic Substances Control Act Seminar, Washington, D.C. (April 25, 2017). Presenter: Michael Boucher.
  • "Regulation of Existing Chemicals," The Annual Toxic Substances Control Act Seminar, Washington, D.C. (April 25, 2017). Presenter: Michael Boucher.
  • "The Politics and Policy of Pharmaceutical Patents in the New Administration: Town Hall," ACI-11th Annual Paragraph IV Disputes, New York, NY (April 24, 2017). Moderator: Terry Rea.
  • “Orphan Drugs and Market Exclusivity," Medicines for Europe, Legal Affaire Conference, London, U.K. (March 22-23, 2017). Speaker: Kristof Roox.
  • "Roundtable on UPC Developments," Medicines for Europe, Legal Affaire Conference, London, U.K. (March 22-23, 2017). Co-Chair: Kristof Roox.
  • "Under the Watchful Eye of the FDA: What Do FDA Warning Letters Tell Us?" Third Annual ABA Life Sciences Legal Summit, San Francisco, CA (September 21, 2016). Presenter: John Fuson.
  • "Anatomy of a PTO PTAB Patent Trial in the Hatch-Waxman Arena," ACI - Paragraph IV Disputes Master Symposium, Chicago, IL (October 2, 2015). Presenter: Terry Rea.
  • "Corporate Counsel Litigation Forum: Strategies & Trends in Effective Value-Based Billing," Crowell & Moring's Corporate Counsel Litigation Forum Webinar Series (June 23, 2015). Moderator: Jerome A. Murphy; Panelists: Robert A. Lipstein, Matthew Laws, Dr. Silvia Hodges Silverstein, and Justin Ergler.
  • "Cooperating Safely with Competitors," International Chamber of Commerce UK Compliant Collaboration Workshop, London (May 27, 2015). Presenter: Sean-Paul Brankin.
1 2 3  ▶ last